![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, January 09, 2019 4:55:20 PM
I Dabbled in some cheap call options and we will see what happens. With a MC this low and science that I think is valuable, this seems like it makes sense. I just remember the aldox days when we were all excited about the lung cancer trial results that we never got and the big partnership deal we were expecting. As it is now, Soon controls Aldox and it looks like it is going through multiple trials so there could be some upside but CYTR has really nothing to do with it anymore. Then you have the LADR tech, but it seems like early positive results have cause CYTR to shut down trials looking for a deal. So I have a company that created apparently awesome tech, but is now doing nothing. I am somewhat optimistic that paying off the debt, owning LADR tech, closing Germany Lab, creating a spin off company (tho wholly owned by CYTR), the recent lack of shorting, and the Sabby long (please be long) investment all point to a transaction that will once and for all be beneficial to all shareholders....cause if not, I have no idea what they are doing?
Good luck to all!
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM